BIIB CIK: 875045

Biogen Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.87
FY22:
7.90
FY23:
7.30
FY24:
7.37
FY25:
7.49
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.75
FY22:
3.59
FY23:
1.30
FY24:
1.91
FY25:
1.56
(positive)
Change from FY22 to FY25
billions USD
FY21:
–
FY22:
3.50
FY23:
2.60
FY24:
3.02
FY25:
3.40
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.75
FY22:
3.59
FY23:
1.30
FY24:
1.91
FY25:
1.56
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.56
FY22:
3.05
FY23:
1.16
FY24:
1.63
FY25:
1.29

All amounts in billions USD Data sources:SEC EDGARTwelve Data